title: Interaction of ceruloplasmin with eosinophil peroxidase as compared to its interplay with myeloperoxidase: Reciprocal effect on enzymatic properties.
abstract: Myeloperoxidase (MPO) and eosinophil peroxidase (EPO) are involved in the development of halogenative stress during inflammation. We previously described a complex between MPO and ceruloplasmin (CP). Considering the high structural homology between MPO and EPO, we studied the latter's interaction with CP and checked whether EPO becomes inhibited in a complex with CP. Disc-electrophoresis and gel filtration showed that CP and EPO form a complex with the stoichiometry 1:1. Affinity chromatography of EPO on CP-agarose (150 mM NaCl, 10 mM Na-phosphate buffer, of pH 7.4) resulted in retention of EPO. EPO protects ceruloplasmin from limited proteolysis by plasmin. Only intact CP shifted the Soret band typical of EPO from 413 to 408 nm. The contact with CP likely causes changes in the heme pocket of EPO. Peroxidase activity of EPO with substrates such as guaiacol, orcinol, o-dianisidine, 4-chloro-1-naphtol, 3,3',5,5'-tetramethylbenzidine, and 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonate) is inhibited by CP in a dose-dependent manner. Similar to the interaction with MPO, the larger a substrate molecule, the stronger the inhibitory effect of CP upon EPO. The limited proteolysis of CP abrogates its capacity to inhibit the peroxidase activity of EPO. The peptide RPYLKVFNPR (corresponding to amino acids 883-892 in CP) inhibits the peroxidase and chlorinating activity of EPO. Only the chlorinating activity of EPO is efficiently inhibited by CP, while the capacity of EPO to oxidize bromide and thiocyanate practically does not depend on the presence of CP. EPO enhances the p-phenylenediamine-oxidase activity of CP. The structural homology between the sites in the MPO and EPO molecules enabling them to contact CP is discussed.
authors.affiliation: Research Institute of Experimental Medicine , Saint-Petersburg , Russia.
authors.forename: A V
authors.initials: AV
authors.lastname: Sokolov
authors.forename: V A
authors.initials: VA
authors.lastname: Kostevich
authors.forename: E T
authors.initials: ET
authors.lastname: Zakharova
authors.forename: V R
authors.initials: VR
authors.lastname: Samygina
authors.forename: O M
authors.initials: OM
authors.lastname: Panasenko
authors.forename: V B
authors.initials: VB
authors.lastname: Vasilyev
mesh_terms: D000818:Animals; D002570:Ceruloplasmin / Q000378:metabolism*; D004791:Enzyme Inhibitors / Q000378:metabolism; D047209:Eosinophil Peroxidase / Q000037:antagonists & inhibitors / Q000378:metabolism*; D054879:Halogenation; D006801:Humans; D007700:Kinetics; D009195:Peroxidase / Q000037:antagonists & inhibitors / Q000097:blood / Q000276:immunology / Q000378:metabolism*; D011485:Protein Binding; D017434:Protein Structure, Tertiary
chemical_list: D004791:Enzyme Inhibitors; D047209:Eosinophil Peroxidase; D009195:Peroxidase; D002570:Ceruloplasmin
keywords: ceruloplasmin; eosinophil peroxidase; halogenating activity; myeloperoxidase; protein–protein interaction